Companies similar to NURIX THERAPEUTICS INC (NRIX)
Health Care · NASDAQ
NURIX THERAPEUTICS INC (NRIX)'s closest peers include ARVINAS INC (ARVN), KYMERA THERAPEUTICS INC (KYMR), C4 THERAPEUTICS INC (CCCC), MONTE ROSA THERAPEUTICS INC (GLUE), Amgen (AMGN) and Bristol Myers Squibb (BMY). This peer set is drawn from NRIX's enriched company profile and is informational only — not financial advice.
Similar companies
-
ARVINAS INCARVNHealth Care
Arvinas is a pioneer in targeted protein degradation, utilizing its PROTAC platform to develop small molecule therapeutics that eliminate disease-causing…
$8.26 (as of 2026-07-21) · market cap $532M
-
KYMERA THERAPEUTICS INCKYMRHealth Care
Kymera Therapeutics is a pioneer in targeted protein degradation, developing oral small-molecule drugs that mimic the efficacy of injectable biologics for…
$113.37 (as of 2026-07-21) · market cap $9.3B
-
C4 THERAPEUTICS INCCCCCHealth Care
Clinical-stage biotech deploying its proprietary TORPEDO platform to develop first-in-class small-molecule targeted protein degraders for oncology,…
$3.83 (as of 2026-07-21) · market cap $426M
-
MONTE ROSA THERAPEUTICS INCGLUEHealth Care
Monte Rosa Therapeutics develops molecular glue degraders—a novel class of protein degradation drugs targeting historically undruggable proteins through its…
$23.63 (as of 2026-07-21) · market cap $2.0B
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$366.24 (as of 2026-07-21) · market cap $195.6B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
Not quite? Describe exactly what you want →
Peers are drawn from NRIX's enriched profile (the same similarity signal the chat uses for "companies like NRIX"). See the full profile: NURIX THERAPEUTICS INC (NRIX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.